| Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ... Jama 317 (23), 2402-2416, 2017 | 3002 | 2017 |
| Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non … KA Gelmon, M Tischkowitz, H Mackay, K Swenerton, A Robidoux, ... The lancet oncology 12 (9), 852-861, 2011 | 1358 | 2011 |
| Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE N Mavaddat, S Peock, D Frost, S Ellis, R Platte, E Fineberg, DG Evans, ... JNCI: Journal of the National Cancer Institute 105 (11), 812-822, 2013 | 1135 | 2013 |
| Breast-Cancer Risk in Families with Mutations in PALB2 AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, ... New England Journal of Medicine 371 (6), 497-506, 2014 | 1116 | 2014 |
| Gene-panel sequencing and the prediction of breast-cancer risk DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ... New England Journal of Medicine 372 (23), 2243-2257, 2015 | 1045 | 2015 |
| Prevalence and architecture of de novo mutations in developmental disorders Nature 542 (7642), 433-438, 2017 | 970 | 2017 |
| Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer E Castro, C Goh, D Olmos, E Saunders, D Leongamornlert, ... Journal of Clinical Oncology 31 (14), 1748-1757, 2013 | 937 | 2013 |
| Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer S Reid, D Schindler, H Hanenberg, K Barker, S Hanks, R Kalb, ... Nature genetics 39 (2), 162-164, 2007 | 739 | 2007 |
| Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors T Taniguchi, M Tischkowitz, N Ameziane, SV Hodgson, CG Mathew, ... Nature medicine 9 (5), 568-574, 2003 | 717 | 2003 |
| Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers RS van der Post, IP Vogelaar, F Carneiro, P Guilford, D Huntsman, ... Journal of medical genetics 52 (6), 361-374, 2015 | 656 | 2015 |
| BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors A Lee, N Mavaddat, AN Wilcox, AP Cunningham, T Carver, S Hartley, ... Genetics in medicine 21 (8), 1708-1718, 2019 | 637 | 2019 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 585 | 2015 |
| Use of immunohistochemical markers can refine prognosis in triple negative breast cancer M Tischkowitz, JS Brunet, LR Bégin, DG Huntsman, MCU Cheang, ... BMC cancer 7, 1-11, 2007 | 567 | 2007 |
| Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer P Kaurah, A MacMillan, N Boyd, J Senz, A De Luca, N Chun, G Suriano, ... Jama 297 (21), 2360-2372, 2007 | 540 | 2007 |
| Hereditary breast cancer: new genetic developments, new therapeutic avenues PM Campeau, WD Foulkes, MD Tischkowitz Human genetics 124, 31-42, 2008 | 507 | 2008 |
| Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type L Witkowski, J Carrot-Zhang, S Albrecht, S Fahiminiya, N Hamel, ... Nature genetics 46 (5), 438-443, 2014 | 483 | 2014 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 447 | 2017 |
| Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease KJ Carss, G Arno, M Erwood, J Stephens, A Sanchis-Juan, S Hull, K Megy, ... The American Journal of Human Genetics 100 (1), 75-90, 2017 | 444 | 2017 |
| Fanconi anaemia MD Tischkowitz, SV Hodgson Journal of medical genetics 40 (1), 1-10, 2003 | 413 | 2003 |
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 400 | 2017 |
William D. FoulkesProfessor of Oncology, Medicine, and Human Genetics. McGill UniversityVerified email at mail.mcgill.ca
